Crystal structure of a 3-oxoacyl-(acyl carrier protein) reductase (BA3989) from Bacillus anthracis at 2.4-Å resolution

Proteins: Structure, Function and Genetics

Volumn 70, Issue 2, 2008, Pages 562-567

  Zaccai, Nathan R ^a,c   Carter, Lester G ^a,d   Berrow, Nick S ^a   Sainsbury, Sarah ^a   Nettleship, Joanne E ^a   Walter, Thomas S ^a   Harlos, Karl ^a   Owens, Ray J ^a   Wilson, Keith S ^b   Stuart, David I ^a   Esnouf, Robert M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

ketoacyl (acyl carrier protein)reductase; FabG; Fatty acid biosynthesis; Short chain dehydrogenase reductase (SDR); X ray crystallography

Indexed keywords

3 OXOACYL ACYL CARRIER PROTEIN REDUCTASE; ACYL CARRIER PROTEIN; BACTERIAL ENZYME; FATTY ACID; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS ANTHRACIS; BACTERIAL GENOME; BIOSYNTHESIS; CRYSTAL STRUCTURE; CRYSTALLIZATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN STRUCTURE; STEREOCHEMISTRY; X RAY CRYSTALLOGRAPHY;

ALCOHOL OXIDOREDUCTASES; AMINO ACID SEQUENCE; BACILLUS ANTHRACIS; BASE SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DNA PRIMERS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID;

BACILLUS ANTHRACIS;

EID: 37849047180     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21624     Document Type: Article

References (33)

1. Au K, Berrow NS, Blagova E, Boucher IW, Boyle MP, Brannigan JA, Carter LG, Dierks T, Folkers G, Grenha R, Harlos K, Kaptein R, Kalliomaa AK, Levdikov VM, Meier C, Milioti N, Moroz O, Müller A, Owens RJ, Rzechorzek N, Sainsbury S, Stuart DI, Walter TS, Waterman DG, Wilkinson AJ, Wilson KS, Zaccai N, Esnouf RM, Fogg MJ. Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis. Acta Crystallogr 2006;D62:1267-1275.
2. Meier C, Carter LG, Winter G, Owens RJ, Stuart DI, Esnouf RM. Structure of 5-formyltetrahydrofolate cyclo-ligase from Bacillus anthracis (BA4489). Acta Crystallogr 2007;F63:168-172.
3. Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, Holtzapple EK, Okstad OA, Helgason E, Rilstone J, Wu M, Kolonay JF, Beanan MJ, Dodson RJ, Brinkac LM, Gwinn M, DeBoy RT, Madpu R, Daugherty SC, Durkin AS, Haft DH, Nelson WC, Peterson JD, Pop M, Khouri HM, Radune D, Benton JL, Mahamoud Y, Jiang L, Hance IR, Weidman JF, Berry KJ, Plaut RD, Wolf AM, Watkins KL, Nierman WC, Hazen A, Cline R, Redmond C, Thwaite JE, White O, Salzberg SL, Thomason B, Friedlander AM, Koehler TM, Hanna PC, Kolsto AB, Fraser CM. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 2003;423:81-86.
4. Toomey RE, Wakil SJ. Studies on the mechanism of fatty acid synthesis. XV. Preparation and general properties of β-ketoacyl acyl carrier protein reductase from Escherichia coli. Biochim Biophys Acta 1966;116:189-197.
5. Zhang Y, Cronan JE, Jr. Transcriptional analysis of essential genes of the Escherichia coli fatty acid biosynthesis gene cluster by functional replacement with the analogous Salmonella typhimurium gene cluster. J Bacteriol 1998;180:3295-3303.
6. Surolia A, Ramya TN, Ramya V, Surolia N. 'FAS't inhibition of malaria. Biochem J 2004;383:401-412.
7. Ramya TN, Surolia N, Surolia A. Is the fatty acid synthesis pathway a good target for anti-malarial therapy? IUBMB Life 2005;57:371-373.
8. Zhang YM, Lu YJ, Rock CO. The reductase steps of the type II fatty acid synthase as antimicrobial targets. Lipids 2004;39:1055-1060.
9. Zhang YM, Rock CO. Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J Biol Chem 2004;279: 30994-31001.
10. Ren J, Sainsbury S, Berrow NS, Alderton D, Nettleship JE, Stammers DK, Saunders NJ, Owens RJ. Crystal structure of nitrogen regulatory protein IIANtr from Neisseria meningitides. BMC Struct Biol 2005;10:13.
11. Alzari PM, Berglund H, Berrow NS, Blagova E, Busso D, Cambillau C, Campanacci V, Christodoulou E, Eiler S, Fogg MJ, Folkers G, Geerlof A, Hart D, Haouz A, Herman MD, Madeira S, Nordlund P, Perrakis A, Quevillon-Cheruel S, Tarandeau F, van Tilbeurgh H, Unger T, Luna-Vargas MP, Velarde M, Willmanns M, Owens RJ. Implementation of semi-automated cloning and prokaryotic expression screening: the impact of SPINE. Acta Crystallogr 2006;D62: 1103-1113.
12. Luan CH, Qiu S, Finley JB, Carson M, Gray RJ, Huang W, Johnson D, Tsao J, Reboul J, Vaglio P, Hill DE, Vidal M, Delucas LJ, Luo M. High-throughput expression of C. elegans proteins. Genome Res 2004;14:2102-2110.
13. Walter TS, Diprose J, Brown J, Pickford M, Owens RJ, Stuart DI, Harlos K. A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation. J Appl Crystallogr 2003;36:308-314.
14. Brown J, Walter TS, Carter L, Abrescia NGA, Aricescu AR, Batuwangala TD, Bird LE, Brown N, Chamberlain PP, Davis SJ, Dubinina E, Endicott J, Fennelly JA, Gilbert RJC, Harkiolaki M, Hon WC, Kimberley F, Love CA, Mancini EJ, Manso-Sancho R, Nichols CE, Robinson RA, Sutton GC, Schueller N, Sleeman MC, Stewart-Jones GB, Vuong M, Welburn J, Zhang Z, Stammers DK, Owens RJ, Jones EY, Harlos K, Stuart DI. A procedure for setting up high-throughput nanolitre crystallization experiments. II. Crystallization results. J Appl Crystallogr 2003;36:315-318.
15. Walter TS, Diprose JM, Mayo CJ, Siebold C, Pickford MG, Carter L, Sutton GC, Berrow NS, Brown J, Berry IM, Stewart-Jones GB, Grimes JM, Stammers DK, Esnouf RM, Jones EY, Owens RJ, Stuart DI, Harlos K. A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization. Acta Crystallogr 2005;D61:651-657.
16. Otwinowski Z, Minor W. Processing of X-ray diffraction data collection in oscillation mode. Methods Enzymol 1997;276:307-326.
17. Navaza J, Saludjian P. AMoRe: An automated molecular replacement program package. Methods Enzymol 1997;276:581-594.
18. Price AC, Zhang YM, Rock CO, White SW. Cofactor-induced conformational rearrangements establish a catalytically competent active site and a proton relay conduit in FabG. Structure (Camb) 2004;12:417-428.
19. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr 1998;D54:905-921.
20. Jones TA, Zhou JY, Cowan SW, Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr 1991;A47:110-119.
21. Murshudov GN, Vagin AA, Lebedev A, Wilson KS, Dodson EJ. Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr 1999;D55:247-255.
22. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr 2004;D60:2126-2132.
23. Lovell SC, Davis IW, Arendall WB III, de Bakker PI, Word JM, Prisant MG, Richardson JS, Richardson DC. Structure validation by Calpha geometry: phi, psi, and Cbeta deviation. Proteins 2003;50: 437-450.
24. Holm L, Sander C. Protein structure comparison by alignment of distance matrices. J Mol Biol 1993;233:123-138.
25. Krissinel E, Henrick K. Detection of protein assemblies in crystals. In: Berthold MR, Glen R, Diederichs K, Kohlbacher O, Fischer I. editors. CompLife 2005 Proceedings. Berlin/Heidelberg: Springer-Verlag; 2005. pp 163-174.
26. Stuart DI, Levine M, Muirhead H, Stammers DK. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 Å. J Mol Biol 1979;134:109-142.
27. Gouet P, Courcelle E, Stuart DI, Métoz F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 1999;15: 305-308.
28. Esnouf RM. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. Acta Crystallogr 1999;D55:938-940.
29. Merritt EA, Bacon DJ. Raster3D: photorealistic molecular graphics. Methods Enzymol 1997;277:505-524.
30. Andersson A, Jordan D, Schneider G, Lindqvist Y. Crystal structure of the ternary complex of 1,3,8-trihydroxynaphthalene reductase from Magnaporthe grisea with NADPH and an active-site inhibitor. Structure 1996;4:1161-1170.
31. Price AC, Zhang YM, Rock CO, White SW. Structure of beta-ketoacyl-[acyl carrier protein] reductase from Escherichia coli: negative cooperativity and its structural basis. Biochemistry 2001;40: 12772-12781.
32. Fisher M, Kroon JT, Martindale W, Stuitje AR, Slabas AR, Rafferty JB. The X-ray structure of Brassica napus beta-keto acyl carrier protein reductase and its implications for substrate binding and catalysis. Struct Fold Des 2000;8:339-347.
33. Tanaka N, Nonaka T, Nakamura KT, Hara A. SDR: structure, mechanism of action, and substrate recognition. Curr Org Chem 2001; 5:89-111.